Authors
Latest:
Palliative Care Is Not (Necessarily) the EndHospice care is only a part of palliative care services.
Latest:
Unrecognized Costs Associated With Clostridium Difficile Infection: What HCPs Often MissFrom an economic perspective, C. difficile has a staggering financial impact on the US health care system, as well on the patients infected.
Latest:
The Pharmacist's Role in Prior AuthorizationsThe prior authorization process often involves complex transactions and increases the burden not only on physicians and pharmacies, but can also impact patient access.
Latest:
All Pharmacies Are Not the Same: Community Pharmacy QualityPatients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
Latest:
Advise Patients About OTC Options for Treating Motion SicknessMany cases of motion sickness can be managed safely with available OTC products.
Latest:
2023 Forecasts for Pharmacy Services, Medication Costs During the Rise of Personalized MedicineData from a recent survey reflect a resounding shift toward the role of pharmacies becoming sites for primary care.
Latest:
Empower Prospective Pharmacists through Children’s BooksThis short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.
Latest:
Pharmacy Department-Driven Initiative to Reduce Subcutaneous Daratumumab Observation TimeObservation time on subsequent injections of subcutaneous daratumumab may be safely removed from institutional policies to reduce chair time.
Latest:
Clinical Overview: A Novel Way of Treating SchizophreniaThe estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.
Latest:
Getting Medications Right: Five Questions Pharmacists, Physicians Should Ask PatientsWith a coordinated, interprofessional team supporting them, patients are empowered with information at the point-of-care to help manage medication therapy problems as they arise.
Latest:
Patient and Provider Safety is at the Core of Mass COVID-19 Immunization EffortAs new variants of the virus come to rise, it is crucial to continue to address the safety concerns with mass COVID-19 immunizations during the pandemic as well as provide solutions to reduce the exposure and spread of the virus.
Latest:
Clinical Overview: A Novel Way of Treating SchizophreniaThe estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.
Latest:
Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion ClinicPharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Latest:
Board Certification for Medical Science Liaisons: Implications for the Pharmaceutical IndustryMore than ever, confidence in objective, science-based data about therapeutics, such as the COVID-19 vaccine and other health care services, is a shared imperative across the pharmaceutical industry, health care communities, and the American public.
Latest:
Current Standards of Care in Platinum-Resistant Ovarian CancerFolate receptor α may be an important treatment target for ovarian tumors.
Latest:
Drug Shortages in Community Oncology: Ensuring Access to ChemotherapyPersistent chemotherapy drug shortages challenge oncology providers. American Oncology Network employs a drug shortage committee for organized shortage management that involves pharmacists and interdisciplinary stakeholders.
Latest:
New Curricular Framework Aims to Prepare, Inspire the Next Generation of Community Pharmacy LeadersThe framework includes 6 domains designed to immediately empower students in community pharmacies.
Latest:
The Pharmacy Model Is ChangingEmbracing artificial intelligence and other tools will be necessary to push the field forward.
Latest:
More Scrutiny Means Strict Regulation and OpportunityPharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.
Latest:
Assessing Quadruplet vs Triplet Regimens in Up-front Multiple Myeloma TreatmentResearch indicates quadruplet regimens may be a viable option for this disease.
Latest:
Navigating the Shadows: Understanding the Psychology and Pharmacology of Treating Postpartum DepressionA new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.
Latest:
Understand the Effects of Topical Nasal Decongestants on Blood PressureBecause decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
Latest:
Integration of Palliative Pharmacists to Elevate Oncologic CarePalliative pharmacists are invaluable assets of oncologic care.
Latest:
Fecal Microbiota, Live-jslm for the Prevention of Recurrent C difficile InfectionPharmacists play a key role in the use of live biotherapeutic products, including fecal microbiota, live-jslm for prevention of recurrent Clostridioides difficile (C difficile) infection.
Latest:
Sex and Gender Inequalities in Oncology Care and Research PersistStrategies to advance sex and gender equality nationally and globally in oncology have been initiated in recent years.
Latest:
All it Takes is a Conversation: Deprescribing Benzodiazepines in Older AdultsBenzodiazepines have proven effective in managing anxiety and insomnia, but they heighten risk of falls, cognitive impairment, functional decline, and mortality among older adults.
Latest:
Pharmacists Can Leverage Future Roles in Outcomes-Based Payment ModelsThe pharmacist integration model filled in gaps in care that appeared to positively affect MIPS and PCMH quality measures.
Latest:
Pharmacy Technicians Can Master Professional IntegrityAs technicians are increasingly involved in decision-making, they must exude confidence and advocate for themselves
Latest:
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK InhibitorsThis article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
